loadpatents
name:-0.012884140014648
name:-0.012242078781128
name:-0.0030920505523682
Pearce; Bradley C. Patent Filings

Pearce; Bradley C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pearce; Bradley C..The latest application filed is for "isofuranone compounds useful as hpk1 inhibitors".

Company Profile
1.14.11
  • Pearce; Bradley C. - East Hampton CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Isofuranone compounds useful as HPK1 inhibitors
Grant 11,166,959 - Araujo , et al. November 9, 2
2021-11-09
Isofuranone Compounds Useful As Hpk1 Inhibitors
App 20200390776 - Araujo; Erika M.V. ;   et al.
2020-12-17
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors
Grant 9,598,423 - Velaparthi , et al. March 21, 2
2017-03-21
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine Derivatives As Casein Kinase 1 D/e Inhibitors
App 20160311824 - Velaparthi; Upender ;   et al.
2016-10-27
Novel Substituted Pyrazolo-piperazines As Casein Kinase 1 D/e Inhibitors
App 20160122358 - Velaparthi; Upender ;   et al.
2016-05-05
Substituted pyrazolo-piperazines as casein kinase 1 .delta./.epsilon. inhibitors
Grant 9,273,058 - Velaparthi , et al. March 1, 2
2016-03-01
Novel Substituted Pyrazolo-piperazines As Casein Kinase 1 D/e Inhibitors
App 20150133428 - Velaparthi; Upender ;   et al.
2015-05-14
Three-dimensional Structure Of H1n1 Nucleoprotein In Complex With Antiviral Compounds
App 20140011700 - Baldwin; Eric T. ;   et al.
2014-01-09
Piperazine analogs as broad-spectrum influenza antivirals
Grant 8,362,004 - Cianci , et al. January 29, 2
2013-01-29
Novel Piperazine Analogs With Substituted Heteroaryl Groups As Broad-spectrum Influenza Antivirals
App 20120245176 - Cianci; Christopher W. ;   et al.
2012-09-27
Novel Piperazine Analogs As Broad-spectrum Influenza Antivirals
App 20120238539 - Cianci; Christopher W. ;   et al.
2012-09-20
Piperazine amidines as antiviral agents
Grant 7,396,830 - Wang , et al. July 8, 2
2008-07-08
Piperazine amidines as antiviral agents
App 20070078141 - Wang; Tao ;   et al.
2007-04-05
Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
Grant 6,774,134 - Yu , et al. August 10, 2
2004-08-10
Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
Grant 6,573,262 - Wallace , et al. June 3, 2
2003-06-03
Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
App 20030069245 - Wallace, Owen B. ;   et al.
2003-04-10
Benzimidazolone antiviral agents
Grant 6,506,738 - Yu , et al. January 14, 2
2003-01-14
Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
App 20020099208 - Yu, Kuo-Long ;   et al.
2002-07-25
Tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
Grant 5,393,776 - Pearce February 28, 1
1995-02-28
Antihyperlipidemic benzoquinones
Grant 5,318,993 - Pearce June 7, 1
1994-06-07
Farnesylated tetrahydro-naphthalenols as hypolipidemic agents
Grant 5,296,508 - Pearce March 22, 1
1994-03-22
Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
Grant 5,217,992 - Wright , et al. June 8, 1
1993-06-08
Farnesylated tetrahydro-naphthalenols as hypolipidemic agents
Grant 5,204,373 - Pearce April 20, 1
1993-04-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed